We are live on ! Find out more
JNJ icon

Johnson & Johnson

2,598 hedge funds and large institutions have $232B invested in Johnson & Johnson in 2018 Q1 according to their latest regulatory filings, with 96 funds opening new positions, 1,124 increasing their positions, 1,165 reducing their positions, and 89 closing their positions.

New
Increased
Maintained
Reduced
Closed

8% more first-time investments, than exits

New positions opened: 96 | Existing positions closed: 89

0.15% more ownership

Funds ownership: 67.45%67.6% (+0.15%)

1% less funds holding

Funds holding: 2,6242,598 (-26)

4% less repeat investments, than reductions

Existing positions increased: 1,124 | Existing positions reduced: 1,165

8% less capital invested

Capital invested by funds: $253B → $232B (-$20.8B)

13% less funds holding in top 10

Funds holding in top 10: 763663 (-100)

28% less call options, than puts

Call options by funds: $1.25B | Put options by funds: $1.74B

Holders
2,598
Holders Change
-26
Holders Change %
-0.99%
% of All Funds
59.53%
Holding in Top 10
663
Holding in Top 10 Change
-100
Holding in Top 10 Change %
-13.11%
% of All Funds
15.19%
New
96
Increased
1,124
Reduced
1,165
Closed
89
Calls
$1.25B
Puts
$1.74B
Net Calls
-$490M
Net Calls Change
+$448M
Name Holding Trade Value Shares
Change
Change in
Stake
EWM
1076
Edge Wealth Management
New York
$6.06M -$60.4K -447 -0.9%
FAM
1077
Fred Alger Management
New York
$6.02M -$3.71M -27,415 -37%
AC
1078
Addison Capital
Pennsylvania
$6.01M -$45.8K -339 -0.7%
DT
1079
Diversified Trust
Tennessee
$6.01M +$533K +3,945 +9%
RC
1080
Roundview Capital
New Jersey
$6M +$358K +2,650 +6%
WA
1081
WBH Advisory
Maryland
$5.97M +$204K +1,510 +3%
TNBTD
1082
Trustmark National Bank Trust Department
Mississippi
$5.97M -$28.5K -211 -0.5%
LA
1083
LexAurum Advisors
Kansas
$5.96M +$5.79M +42,822 +1,152%
ANBT
1084
American National Bank & Trust
Texas
$5.96M -$1.67M -12,377 -21%
RIM
1085
Regent Investment Management
Kentucky
$5.96M -$94.5K -699 -1%
GC
1086
Grimes & Company
Massachusetts
$5.93M +$545K +4,031 +10%
BAAM
1087
Baker Avenue Asset Management
California
$5.92M -$85.3K -631 -1%
SCA
1088
Sage Capital Advisors
South Dakota
$5.92M +$9.06K +67 +0.1%
SFM
1089
Systematic Financial Management
New Jersey
$5.9M -$34.2K -253 -0.5%
CL
1090
CPWM LLC
Washington
$5.9M +$4.64M +34,310 +292%
BA
1091
BCM Advisors
Louisiana
$5.87M +$19.2K +142 +0.3%
LPT
1092
Legacy Private Trust
Wisconsin
$5.87M +$22.3K +165 +0.4%
SFSG
1093
Stearns Financial Services Group
North Carolina
$5.83M -$348K -2,576 -5%
BSW
1094
Buckingham Strategic Wealth
Missouri
$5.78M +$260K +1,920 +4%
Tudor Investment Corp
1095
Tudor Investment Corp
Connecticut
$5.78M +$6.1M +45,103 New
AAIM
1096
American Assets Investment Management
California
$5.77M
VHAM
1097
Van Hulzen Asset Management
California
$5.76M +$1.67M +12,373 +38%
Aristotle Capital Management
1098
Aristotle Capital Management
California
$5.75M +$26.1K +193 +0.4%
FBC
1099
Fairfield, Bush & Co
Connecticut
$5.75M -$405 -3 -0%
MAM
1100
Morse Asset Management
Connecticut
$5.75M -$332K -2,455 -5%

JNJ Hedge Fund Activity: Q1 2018 in Review

2,598 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q1 2018, worth a combined $232B — down 8.2% from $253B a quarter earlier.

Buyers outnumbered sellers: 96 funds opened new JNJ positions and 89 closed out — a net gain of 7 holders — while 1,124 added to existing stakes and 1,165 trimmed.

The largest buyer was BlackRock, adding an estimated $1.06B. The largest seller was Wellington Management Group, cutting an estimated $787M.

  • 2,598 institutional investors held Johnson & Johnson (JNJ) as of Q1 2018, down from 2,624 in Q4 2017.
  • Funds reported $232B of Johnson & Johnson stock for Q1 2018, down 8.2% quarter-over-quarter.
  • 96 funds opened new Johnson & Johnson positions in Q1 2018 and 89 closed out, a net change of +7 holders.
  • The largest Johnson & Johnson buyer in Q1 2018 was BlackRock, an estimated $1.06B added.
  • The largest Johnson & Johnson seller in Q1 2018 was Wellington Management Group, an estimated $787M sold.

Based on aggregated 13F filings for Q1 2018.